If youre covered by Medicare or Medicaid, you might have different coverage options
The SUSTAIN and STEP trial data consistently showed cardiometabolic improvements in lipid profiles alongside weight loss, which is part of why semaglutide received approval for cardiovascular risk reduction in certain populations
Splitting doses or changing the frequency pattern can introduce unpredictability into your treatment, potentially reducing how well the medication suppresses your appetite or manages blood sugar levels
Regarding lipid changes, patients should not expect dramatic or immediate improvements in cholesterol levels
The special formulation that allows for rapid dissolution may not be uniformly distributed throughout the tablet, meaning that splitting could result in uneven doses of the active ingredients
Once injected, semaglutide binds to GLP-1 receptors in different parts of the body, mimicking the effects of natural GLP-1